Mechanism of inhibition of retrovirus release from cells by interferon-induced gene ISG15

Journal of Virology

Volumn 85, Issue 14, 2011, Pages 7153-7161

  Kuang, Zhizhou ^a   Seo, Eun Joo ^a   Leis, Jonathan ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CELL PROTEIN; ESCRT III PROTEIN; ESCRT PROTEIN; INTERFERON; MUTANT PROTEIN; PROTEIN CHMP2A; PROTEIN CHMP4B; PROTEIN CHMP5; PROTEIN CHMP6; PROTEIN LIP5; PROTEIN VPS4; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; AVIAN SARCOMA VIRUS; CELL MEMBRANE; CONTROLLED STUDY; CYTOSOL; ENZYME BINDING; HUMAN; HUMAN CELL; ISG15 GENE; LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; RETROVIRUS; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS INHIBITION; VIRUS RELEASE;

BLOTTING, WESTERN; CELL LINE; CYTOKINES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; INTERFERONS; MUTAGENESIS, SITE-DIRECTED; RETROVIRIDAE; RNA, SMALL INTERFERING; UBIQUITINS; VIRUS REPLICATION;

AVES;

EID: 79960406323     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02610-10     Document Type: Article

References (45)

1. Azmi, I. F., et al. 2008. ESCRT-III family members stimulate VPS4 ATPase activity directly or via Vta1. Dev. Cell 14, 50-61.
2. Babst, M. 2005. A protein's final ESCRT. Traffic 6, 2-9.
3. Bednarik, D. P., J. D. Mosca, N. B. Raaj, and P. M. Pitha. 1989. Inhibition of human immunodeficiency virus (HIV) replication by HIV-trans-activated alpha 2-interferon. Proc. Natl. Acad. Sci. U. S. A. 86, 4958-4962.
4. Dastur, A., S. Beaudenon, M. Kelley, R. Klug, and J. Huibregtse. 2006. Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells. J. Biol. Chem. 281, 4334-4338.
5. Demirov, D. G., and E. O. Freed. 2004. Retrovirus budding. Virus Res. 106, 87-102.
6. Garrus, J. E., et al. 2001. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107, 55-65.
7. Giannakopoulos, N. V., et al. 2009. ISG15 Arg151 and the ISG15-conjugating enzyme UbE1L are important for innate immune control of Sindbis virus. J. Virol. 83, 1602-1610.
8. Göttlinger, H. G., T. Dorfman, J. G. Sodriski, and W. A. Haseltine. 1991. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc. Natl. Acad. Sci. U. S. A. 88, 3195-3199.
9. Gottwein, E., et al. 2003. The Mason-Pfizer monkey virus PPPY and PSAP motifs both contribute to virus release. J. Virol. 77, 9474-9485.
10. Kieffer, C., et al. 2008. Two distinct modes of ESCRT-III recognition are required for VPS4 functions in lysosomal protein targeting and HIV-1 budding. Dev. Cell 15, 62-73.
11. Kikonyogo, A., et al. 2001. Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for Gag budding from cells. Proc. Natl. Acad. Sci. U. S. A. 98, 11199-11204.
12. Lata, S., et al. 2009. Structure and function of ESCTR-III. Biochem. Soc. Trans. 37, 156-160.
13. Lenschow, D., et al. 2005. Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo. J. Virol. 79, 13974-13983.
14. Malakhova, O., and D. Zhang. 2008. ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response. J. Biol. Chem. 283, 8783-8787.
15. Martin-Serrano, J. 2007. The role of ubiquitin in retroviral egress. Traffic 8, 1297-1303.
16. Medina, G., et al. 2005. The functionally exchangeable L domains in RSV and HIV-1 Gag direct particle release through pathways linked by Tsg101. Traffic 6, 880-894.
17. Medina, G., et al. 2008. Tsg101 can replace Nedd4 function in ASV Gag release but not membrane targeting. Virology 377, 30-38.
18. Miller, J., Z. Ge, S. Morris, K. Das, and J. Leis. 1997. Multiple biological roles associated with the Rous sarcoma virus 5' untranslated RNA U5-IR stem and loop. J. Virol. 71, 7648-7656.
19. Okumura, A., G. Lu, I. Pitha-Rowe, and P. M. Pitha. 2006. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc. Natl. Acad. Sci. U. S. A. 103, 1440-1445.
20. Okumura, A., P. M. Pitha, and R. N. Harty. 2008. ISG15 inhibits Ebola VP40 budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc. Natl. Acad. Sci. U. S. A. 105, 3974-3979.
21. Patnaik, A., V. Chau, and J. W. Wills. 2000. Ubiquitin is part of the retrovirus budding machinery. Proc. Natl. Acad. Sci. U. S. A. 97, 13069-13074.
22. Pawliczek, T., and C. Crump. 2009. Herpes simplex virus type 1 production requires a functional ESCRT-III complex but is independent of Tsg101 and Alix expression. J. Virol. 83, 11254-11264.
23. Pincetic, A., G. Medina, C. Carter, and J. Leis. 2008. Avian sarcoma virus and human immunodeficiency virus, type 1 use different subsets of ESCRT proteins to facilitate the budding process. J. Biol. Chem. 283, 29822-29830.
24. Pincetic, A., and J. Leis. 2009. The mechanism of budding of retroviruses from cell membranes. Adv. Virol. 2009, 6239691-6239699.
25. Pincetic, A., Z. Kuang, E. J. Seo, and J. Leis. 2010. The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process. J. Virol. 84, 4725-4736.
26. Pitha, P. M., B. Fernie, F. Maldarelli, T. Hattman, and N. A. Wivel. 1980. Effect of interferon on mouse leukaemia virus (MuLV). V. Abnormal proteins on virions of Rauscher MuLV produced in the presence of interferon. J. Gen. Virol. 46, 97-110.
27. Poli, G., J. M. Orenstein, A. Kinter, T. M. Folks, and A. S. Fauci. 1989. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines. Science 244, 575-577.
28. Schmitt, A., G. Leser, D. Waning, and R. Lamb. 2002. Requirements for budding of paramyxovirus simian virus 5 virus-like particles. J. Virol. 76, 3952-3964.
29. Schmitt, A., G. Leser, E. Morita, W. Sunquist, and R. Lamb. 2005. Evidence for a new viral late-domain core sequence, FPIV, necessary for budding of a paramyxovirus. J. Virol. 79, 2988-2997.
30. Scott, A., et al. 2005. Structural and mechanistic studies of VPS4 proteins. EMBO J. 24, 3658-3669.
31. Sekellick, M., A. Ferrandino, D. Hopkins, and P. Marcus. 1994. Chicken interferon gene, cloning, expression, and analysis. J. Interferon Res. 14, 71-79.
32. Shim, S., S. A. Merrill, and P. I. Hanson. 2008. Novel interactions of ESCRT-III with LIP5 and VPS4 and their implications for ESCRT-III disassembly. Mol. Biol. Cell 19, 2661-2672.
33. Shirazi, Y., and P. M. Pitha. 1992. Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle. J. Virol. 66, 1321-1328.
34. Stuchell-Brereton, M. D., et al. 2007. ESCRT-III recognition by VPS4 ATPases. Nature 449, 740-744.
35. Taylor, G., P. Hanson, and M. Kielian. 2007. Ubiquitin depletion and dominant-negative VPS4 inhibit rhabdovirus budding without affecting alphavirus budding. J. Virol. 81, 13631-13639.
36. Timmins, J., et al. 2003. Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4. J. Mol. Biol. 326, 493-502.
37. Vana, M. L., et al. 2004. The role of Nedd4 and ubiquitination of RSV Gag in budding of virus-like particles from cells. J. Virol. 78, 13943-13953.
38. VerPlank, L., et al. 2001. Tsg101, the prototype of a class of dominantnegative ubiquitin regulators, binds human immunodeficiency virus type 1 Pr55Gag, the L domain is a determining of binding. Proc. Natl. Acad. Sci. U. S. A. 98, 7724-7729.
39. von Schwedler, U., et al. 2003. The protein network of HIV budding. Cell 114, 701-713.
40. Ward, D. M., et al. 2005. The role of LIP5 and CHMP5 in multivesicular body formation and HIV-1 budding in mammalian cells. J. Biol. Chem. 280, 10548-10555.
41. Wills, J., et al. 1994. An assembly domain of Rous sarcoma virus Gag protein required late in budding. J. Virol. 68, 6605-6618.
42. Xiang, Y., C. Cameron, J. Wills, and J. Leis. 1996. Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain. J. Virol. 70, 5695-5700.
43. Yuan, W., and R. Krug. 2001. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J. 20, 362-371.
44. Zhao, C., C. Denison, J. M. Huibregtse, S. Gygi, and R. M. Krug. 2005. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc. Natl. Acad. Sci. U. S. A. 102, 10200-10205.
45. Zou, W., et al. 2005. ISG15 modification of ubiquitin E2 Ubc13 disrupts its ability to form thioester bond with ubiquitin. BBRC 336, 61-68.